{"id":300247,"date":"2026-07-09T05:01:10","date_gmt":"2026-07-09T05:01:10","guid":{"rendered":"https:\/\/www.europesays.com\/se\/300247\/"},"modified":"2026-07-09T05:01:10","modified_gmt":"2026-07-09T05:01:10","slug":"riktad-emission-och-aterkop-c-aktier-for-ltip-program-oms","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/300247\/","title":{"rendered":"RIKTAD EMISSION OCH \u00c5TERK\u00d6P C-AKTIER F\u00d6R LTIP-PROGRAM (OMS)"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">(Oms\u00e4ndning: skickades f\u00f6rsta g\u00e5ngen p\u00e5 onsdagskv\u00e4llen)<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">STOCKHOLM (Nyhetsbyr\u00e5n Direkt) Medicinteknikbolaget Bactiguard har beslutat om en riktad nyemission och omedelbart \u00e5terk\u00f6p av C-aktier, med st\u00f6d fr\u00e5n bemyndigandet fr\u00e5n \u00e5rsst\u00e4mman.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Det framg\u00e5r av ett pressmeddelande.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">\u00c5tg\u00e4rderna syftar till att s\u00e4kerst\u00e4lla Bactiguards m\u00f6jlighet att leverera aktier till deltagare i det l\u00e5ngsiktiga incitamentsprogrammet &#8221;LTIP 2026&#8243;&#8217;.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Styrelsen har beslutat om att emittera 715.000 aktier av serien C och d\u00e4refter genomf\u00f6ra ett \u00e5terk\u00f6p av samtliga aktier i serien enligt villkoren i LTIP 2026.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Bolagets aktiekapital kommer att \u00f6ka med 17.875 kronor efter \u00e5terk\u00f6pet och den riktade nyemissionen.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">C-aktierna kommer att omvandlas till B-aktier i samband med att B-aktierna levereras till deltagarna ocks\u00e5 enligt villkoren f\u00f6r LTIP 2026.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">B\u00f6rsredaktionen +46 8 51917911 https:\/\/twitter.com\/Borsredaktion<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Nyhetsbyr\u00e5n Direkt<\/p>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"(Oms\u00e4ndning: skickades f\u00f6rsta g\u00e5ngen p\u00e5 onsdagskv\u00e4llen) STOCKHOLM (Nyhetsbyr\u00e5n Direkt) Medicinteknikbolaget Bactiguard har beslutat om en riktad nyemission och&hellip;\n","protected":false},"author":2,"featured_media":299762,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[28406,22,23,26,27,17,21,24,25,28,29,15,16,18,34,31,33,32,30,19,20],"class_list":["post-300247","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rubriker","tag-bactiguard","tag-breaking-news","tag-breakingnews","tag-featured-news","tag-featurednews","tag-headlines","tag-huvudnyheter","tag-latest-news","tag-latestnews","tag-main-news","tag-mainnews","tag-news","tag-nyheter","tag-rubriker","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-top-stories","tag-topstories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116888265458783550","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/300247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=300247"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/300247\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/299762"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=300247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=300247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=300247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}